| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 13.848 | 31.292 | 46.838 | 56.444 | 40.339 | 29.150 |
| Total Income - EUR | - | - | - | - | 13.848 | 31.292 | 46.838 | 56.444 | 40.339 | 29.150 |
| Total Expenses - EUR | - | - | - | - | 3.603 | 12.940 | 11.061 | 15.066 | 18.116 | 17.682 |
| Gross Profit/Loss - EUR | - | - | - | - | 10.245 | 18.352 | 35.777 | 41.379 | 22.224 | 11.468 |
| Net Profit/Loss - EUR | - | - | - | - | 10.106 | 18.039 | 35.318 | 40.882 | 21.869 | 9.633 |
| Employees | - | - | - | - | 0 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Nutra Pharma Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 10.914 | 31.097 | 70.349 | 48.178 | 35.394 | 44.024 |
| Inventories | - | - | - | - | 20 | 20 | 19 | 19 | 19 | 19 |
| Receivables | - | - | - | - | 10 | 7.360 | 8.751 | 47.723 | 25.233 | 41.174 |
| Cash | - | - | - | - | 10.884 | 23.718 | 61.579 | 436 | 10.142 | 2.831 |
| Shareholders Funds | - | - | - | - | 10.149 | 27.995 | 62.693 | 40.923 | 25.976 | 34.862 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 765 | 3.102 | 7.656 | 7.255 | 9.417 | 9.162 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6310 - 6310" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Nutra Pharma Consulting S.r.l.